Moderna's IPO highest ever for a biotech firm

By hotmaillogin

Biotechnology startup Moderna Inc. has received US$604.3mn this week, making it the industry’s largest initial public offering to date, MarketWatch reports. The company, based in Cambridge, Massachusetts, sold approximately 26.3 million shares priced at $23 each late on Thursday.

Although Moderna’s share price fell in within expected margins of $22-$24, the “offering was larger than expected, raising $604.3 million and valuing the company at around $7.5 billion.” The company listed 10 underwriters to the IPO filing, including Morgan Stanley, Goldman Sachs and JP Morgan.

Moderna has raised a total of $2.6bn in investments and venture capital funding since its founding in 2009.

SEE ALSO: 

The company’s product is centered around the potential medical applications of mRNA, which it calls the “software of life”. MarketWatch reports: “cells use mRNA to translate DNA into the proteins the body uses to function. Moderna believes it can use mRNA to spur the body to produce its own therapeutic proteins, essentially putting a drug factory inside of the patient.”

While mRNA therapies are predicted to be years away from a marketable product, the potential applications span from infectious disease, oncology, cardiovascular disease and rare genetic diseases. Currently, Moderna has 21 drugs under development, 10 of which are in clinical trials.

Moderna now trades on the Nasdaq under the symbol ‘MRNA’.

Share

Featured Articles

DEI done right: Brook Sims, COO, MAC Diversity Recruiters

Passionate about helping others find their voice, diversity leader and COO Brook Sims talks powerful leadership, diverse teams and being a change agent

Q&A: China’s ecommerce innovator Jeff Li, CEO of Shoplazza

Named in Fortune China’s 40 under 40 for 2022, former Baidu head Jeff Li is the entrepreneurial founder and CEO of ecommerce platform Shoplazza

How hybrid work is revolutionising the physical office

As hybrid work models roll out worldwide, the purpose of the office is changing with collaboration, connection and networking taking centre stage

Trailblazer: Shanique Bonelli-Moore, DEI chief at Clorox

Sustainability

Dean Forbes – the Forterro CEO aiming for the moon

Leadership & Strategy

Why becoming a B Corp is good for business

Sustainability